RxSight (RXST) Cash & Equivalents (2020 - 2026)
RxSight's (RXST) quarterly Cash & Equivalents came in at $217.9 million in Q1 2026, down 4.97% YoY from $229.3 million in Q1 2025, and down 4.47% on a QoQ basis from $228.1 million in Q4 2025.
RxSight (RXST) Cash & Equivalents (2020 - 2026) Analysis & Trends
RxSight (RXST) has 7 years of Cash & Equivalents data on file, last reported at $217.9 million in Q1 2026.
- Quarterly Cash & Equivalents fell 4.97% year-over-year to $217.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $217.9 million (down 4.97% YoY) and the FY2025 annual result came in at $228.1 million, up 1265.38% from the prior year.
- Cash & Equivalents fell to $217.9 million in Q1 2026, from $228.1 million in the prior quarter.
- In the past five years, Cash & Equivalents ranged from a high of $233.2 million in Q2 2024 to a low of $16.7 million in Q4 2024.
- A 5-year average of $143.2 million and a median of $131.9 million in 2023 frame the typical range for Cash & Equivalents.
- Annual changes were most pronounced in 2024 — Cash & Equivalents sank 87.32% — and 2025, when it surged 1265.38%.
- Tracing RXST's Cash & Equivalents over 5 years: stood at $105.8 million in 2022, then advanced by 20.23% to $127.2 million in 2023, then sank by 86.87% to $16.7 million in 2024, then surged by 1265.38% to $228.1 million in 2025, then retreated by 4.47% to $217.9 million in 2026.
- The last three Cash & Equivalents figures came in at $217.9 million (Q1 2026), $228.1 million (Q4 2025), and $227.5 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.46 Bn | 193.86 Bn | 7.27 Bn | 5.10 Bn |
| 2 | Stryker | 127.41 Bn | 123.93 Bn | 4.50 Bn | 3.39 Bn |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 1.95 Bn |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 539.00 Mn |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.69 Bn | 1.35 Bn | 2.91 Bn |
| 6 | Dexcom | 34.30 Bn | 32.35 Bn | 830.00 Mn | 1.11 Bn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 2.11 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.02 Bn | 4.55 Bn | 3.25 Bn |
| 9 | Steris | 23.04 Bn | 22.55 Bn | 684.20 Mn | 482.30 Mn |
| 10 | RxSight | 250.40 Mn | -153.85 Mn | - | 208.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 208.80 Mn |
| Mar 31, 2026 | 217.90 Mn |
| Dec 31, 2025 | 228.10 Mn |
| Sep 30, 2025 | 227.50 Mn |
| Jun 30, 2025 | 227.50 Mn |
| Mar 31, 2025 | 229.30 Mn |
| Dec 31, 2024 | 16.71 Mn |
| Sep 30, 2024 | 16.72 Mn |
| Jun 30, 2024 | 233.20 Mn |
| Mar 31, 2024 | 117.51 Mn |
| Dec 31, 2023 | 127.20 Mn |
| Sep 30, 2023 | 131.90 Mn |
| Jun 30, 2023 | 147.10 Mn |
| Mar 31, 2023 | 148.31 Mn |
| Dec 31, 2022 | 105.80 Mn |
| Sep 30, 2022 | 107.95 Mn |
| Jun 30, 2022 | 127.45 Mn |
| Mar 31, 2022 | 24.13 Mn |
| Dec 31, 2021 | 159.30 Mn |
| Sep 30, 2021 | 165.35 Mn |